MedTrace Logo

Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries

NCT05913180 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-12-30

No results posted yet for this study

Summary

Double-blind placebo-controlled randomized trial aiming to assess the role of Vitamin C supplementation in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

Conditions

  • Catheter-Associated Urinary Tract Infection

Interventions

DRUG

Ascorbic Acid 1000 MG

1000mg Ascorbic acid orally daily started on the day of elective gynecological surgery for 10 days

DRUG

Placebo

Placebo tablet daily starting day of elective gynecological surgery for 10 days

Sponsors & Collaborators

  • Moscow State University of Medicine and Dentistry

    collaborator OTHER

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Tony Bazi, M.D. · American University of Beirut Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-19
Primary Completion
2026-08-15
Completion
2026-08-15

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913180 on ClinicalTrials.gov